Paul Brown

Paul Brown


Email [email protected]​

Phone +44 20 7296 2105

Fax +44 20 7296 2001

Practice groupIntellectual Property, Media, and Technology

"tremendous litigator who is astonishingly bright and has no problems handling complex international matters"

IAM Patent 1000, 2018

Paul Brown’s primary focus is on patents in the electronics and medical devices sector. His practice is multi-jurisdictional and predominantly litigious, although he also advises clients in relation to licensing and strategic planning. In the electronics sector, Paul advises a variety of clients on both assertion of patents and defence against infringement claims in disputes concerning essential and non-essential technologies, and is dubbed the 'mobile phones expert' by Legal 500, 2015.

In conjunction with the Hogan Lovells Competition Law practice, Paul also advises clients on the overlap between competition law and IP, including on issues such as the availability of injunctions on essential patents and other aspects of FRAND obligations. In the medical device sector, Paul has represented clients in cases relating to coronary stents and also septal defect occlusion devices.

Awards and recognitions


Patent Litigation
Chambers UK


Intellectual Property
Legal 500


Patent Practitioners
IAM Patent 1000


Patent Star
IP Stars


Who's Who Legal

Education and admissions


LL.M., University College London, 2000

LL.B., University College London, 1999


Member, Chartered Institute of Patent Attorneys

Member, AIPPI

Representative experience

Representing HTC in multiple litigations in the UK, including against IPCom, against Philips and against Nokia in litigation relating to over 30 patents.

Representing a major telecoms network in litigation with a non-practising entity over the FRAND value of a licence of a portfolio of alleged SEPs.

Representing ZTE against Ericsson in patent litigation proceedings relating to standard essential patents.

Representing Garmin against TomTom in multi-patent litigation relating to user interfaces.

Representing AGA Medical Corporation (now Abbott Laboratories) in patent litigation against Occlutech relating to atrial septal defect occluders.

Representing Medinol against Abbott in English and Irish patent litigation proceedings relating to coronary stents.

Representing Merz Pharma against Synthon in an action about Supplementary Protection Certificates.

Providing an opinion on infringement, and non-infringement arguments, in relation to mechanical products for a major engine producer.

Loading data